← Leaderboards
Bret R Rutherford
New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
$14,573,720
Attributed
$15,475,205
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2010–21$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$15,475,205 · 9
By mechanism
R01$10,504,512 · 4
R33$2,165,997 · 1
R61$1,295,876 · 1
K23$882,888 · 1
R21$458,598 · 1
K24$167,334 · 1
Top collaborators
- Patrick J Brown6 shared
Most similar at New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
Same institution · by research overlap
- Guillermo Horga$11,563,576
- Patrick J Brown$2,828,573
- David Pagliaccio$3,785,078
- Ragy Ramsis Girgis$7,968,810
- Jack Grinband$969,023
Others in their field
Top investigators on “Cognitive”
- David R. Weir · University Of Michigan At Ann Arbor$380,402,429
- Paul S. Aisen · Cognition Therapeutics, Inc.$185,453,129
- Randall J Bateman · Washington University$179,917,643
- Reisa A. Sperling · Banner Health$160,454,465
- Michael W Weiner · Northern California Institute Res &Educ$153,571,751
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$118,618,221
Research focus
CognitiveMental DepressionMagnetic Resonance ImagingRandomizedRelating To Nervous SystemLeadDepressive SymptomsAntidepressive AgentsElderlyAdultOlder PatientDisabilityStructurePharmaceutical PreparationsGeriatric DepressionAgingPathway InteractionsDesignChronicNeuroimagingDepressed MoodLinkClinical TrialsIndexing
Grant awards (32)
Cognitive and Neural Mechanisms of the Accelerated Aging Phenotype in PTSD$916,339
R01 · FY2021 · MH · contact PI
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)$752,890
R01 · FY2021 · MH · contact PI
Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression$714,709
R33 · FY2021 · MH · contact PI
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.$347,744
R01 · FY2021 · MH
Mentoring to Develop Aging-Informed Patient-Oriented Research in Neuropsychiatry$167,334
K24 · FY2021 · MH · contact PI
Cognitive and Neural Mechanisms of the Accelerated Aging Phenotype in PTSD$920,216
R01 · FY2020 · MH · contact PI
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)$823,733
R01 · FY2020 · MH · contact PI
Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression$714,709
R33 · FY2020 · MH · contact PI
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.$348,044
R01 · FY2020 · MH
Cognitive and Neural Mechanisms of the Accelerated Aging Phenotype in PTSD$920,217
R01 · FY2019 · MH · contact PI
Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression$736,579
R33 · FY2019 · MH · contact PI
Cognitive and Neural Mechanisms of the Accelerated Aging Phenotype in PTSD$416,191
R01 · FY2019 · MH · contact PI
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.$348,334
R01 · FY2019 · MH
Sensation and Psychiatry: Linking Age-Related Hearing Loss toLate-Life Depression and Cognitive Decline$241,794
R21 · FY2019 · AG · contact PI
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.$86,343
R01 · FY2019 · MH
Cognitive and Neural Mechanisms of the Accelerated Aging Phenotype in PTSD$920,216
R01 · FY2018 · MH · contact PI
Mechanisms of Antidepressant Non-Response in Late-Life Depression$398,758
R01 · FY2018 · MH · contact PI
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.$348,616
R01 · FY2018 · MH
Sensation and Psychiatry: Linking Age-Related Hearing Loss to Late-Life Depression and Cognitive Decline$216,804
R21 · FY2018 · AG · contact PI
Cognitive and Neural Mechanisms of the Accelerated Aging Phenotype in PTSD$1,007,929
R01 · FY2017 · MH · contact PI
Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression$639,170
R61 · FY2017 · MH · contact PI
Mechanisms of Antidepressant Non-Response in Late-Life Depression$398,756
R01 · FY2017 · MH · contact PI
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.$323,890
R01 · FY2017 · MH
Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression$656,706
R61 · FY2016 · MH · contact PI
Mechanisms of Antidepressant Non-Response in Late-Life Depression$398,768
R01 · FY2016 · MH · contact PI
Mechanisms of Antidepressant Non-Response in Late-Life Depression$399,492
R01 · FY2015 · MH · contact PI
Mechanisms of Antidepressant Non-Response in Late-Life Depression$428,036
R01 · FY2014 · MH · contact PI
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms$140,792
K23 · FY2014 · MH · contact PI
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms$184,856
K23 · FY2013 · MH · contact PI
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms$184,856
K23 · FY2012 · MH · contact PI
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms$186,192
K23 · FY2011 · MH · contact PI
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms$186,192
K23 · FY2010 · MH · contact PI